Alector, Inc. is a clinical-stage biotechnology company developing therapies for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Lewy body dementia. Its pipeline includes nivisnebart, a progranulin-elevating antibody in Phase 2 for early AD co-developed with GSK, plus preclinical programs AL137 (anti-amyloid beta), AL050 (GCase enzyme replacement), and ABC-enabled siRNA candidates targeting tau, alpha-synuclein, and NLRP3, all leveraging its proprietary Alector Brain Carrier (ABC) blood-brain barrier delivery platform.
expected 2026-11-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-071593 | EDGAR | 87K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027758 | EDGAR | 90K words |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021183 | EDGAR | 89K words |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005111 | EDGAR | 88K words |
| 2022-02-24 | 2021-12-31 | 0000950170-22-001979 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008860 | EDGAR | — |
| 2020-03-24 | 2019-12-31 | 0001564590-20-012520 | EDGAR | — |
| 2019-03-26 | 2018-12-31 | 0001564590-19-009358 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338052 | EDGAR | 58K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269592 | EDGAR | 61K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105050 | EDGAR | 59K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066987 | EDGAR | 56K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122328 | EDGAR | 56K words |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092814 | EDGAR | 56K words |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055682 | EDGAR | 53K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060270 | EDGAR | 56K words |
| 2023-08-03 | 2023-06-30 | 0000950170-23-038023 | EDGAR | 57K words |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017874 | EDGAR | 53K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023249 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014810 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-338008 | EDGAR | 2K words |
| 2026-02-25 | 0001193125-26-071557 | EDGAR | 2K words |
| 2025-12-12 | 0001193125-25-317554 | EDGAR | 0K words |
| 2025-11-06 | 0001193125-25-269537 | EDGAR | 2K words |
| 2025-10-21 | 0001193125-25-245102 | EDGAR | 1K words |
| 2025-08-07 | 0000950170-25-105023 | EDGAR | 3K words |
| 2025-06-13 | 0001193125-25-140731 | EDGAR | 1K words |
| 2025-05-08 | 0000950170-25-066945 | EDGAR | 2K words |
| 2025-03-28 | 0000950170-25-046756 | EDGAR | 1K words |
| 2025-03-10 | 0001193125-25-050448 | EDGAR | 1K words |
125 total filings indexed. 95 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001653087 |
| Ticker | ALEC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.alector.com |
| Listed | 2019-02-07 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ALEC (~200 tokens, structured JSON with cryptographic provenance)